
|Articles|April 3, 2013
Bausch + Lomb files for initial public offering
Bausch + Lomb has filed a registration statement with the U.S. Securities and Exchange Commission relating to the proposed initial public offering of its common stock.
Advertisement
Rochester, NY-Bausch + Lomb has filed a registration statement with the U.S. Securities and Exchange Commission relating to the proposed initial public offering of its common stock.
A registration statement relating to these securities has been filed with the Securities and Exchange Commission, but has not yet become effective. The number of shares to be offered and the price range for the proposed offering have not yet been determined.
For more articles in this issue of Ophthalmology Times eReport,
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
FDA guidance to help accelerate cell and gene therapies
2
Oculis phase 3 DIAMOND trials miss vision endpoints in diabetic macular edema
3
Closing the gap: John Berdahl, MD, on the global cataract burden and the emerging dementia connection
4
The Residency Report: Cardiovascular risk scores as a window into ocular disease
5





















